Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | TK1 | P04183 | 7/20 | 0.42 |
| ▸ | DUT | P33316 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | TK2 | O00142 | 4/20 | 0.35 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11750378 | 0.86 | KIF11 (0.45) | KIF11SLC6A1KMT2A | |
| SCHEMBL5324252 | 0.78 | KIF11 (0.50) | KIF11TK1DUTTSHRHRH4 | |
| SCHEMBL9371537 | 0.75 | KIF11 (0.47) | KIF11TK1DUTCYP2C9ALOX15 | |
| SCHEMBL9865376 | 0.75 | KIF11 (0.56) | KIF11TK1DUTCYP2C9ALOX15 | |
| SCHEMBL11275984 | 0.74 | KIF11 (0.74) | KIF11TK1DUTCYP2C9ALOX15 | |
| SCHEMBL183489 | 0.70 | KIF11 (0.40) | KIF11ALOX15TSHRCYP2C19MEN1 | |
| SCHEMBL2350021 | 0.70 | KIF11 (0.56) | KIF11TK1DUTALOX15TK2 | |
| SCHEMBL6241174 | 0.70 | KIF11 (0.56) | KIF11DUTCYP2C9ALOX15TSHR | |
| SCHEMBL5735020 | 0.70 | KIF11 (0.56) | KIF11TK1DUTCYP2C9ALOX15 | |
| SCHEMBL13092422 | 0.70 | KIF11 (0.68) | KIF11DUTTSHRHRH4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0898575-B1 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT DR (US) | 2004-12-29 | — | — | EP | claimed |
| US-20040142946-A1 | Modified nucleosides and nucleotides and use thereof | CHATTOPADHYAYA JYOTI (SE) | 2004-07-22 | — | — | US | claimed |
| US-20030194741-A1 | COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-10-16 | — | — | US | claimed |
| EP-1332150-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF | Chattopadhyaya, Jyoti (SE) | 2003-08-06 | — | — | EP | claimed |
| US-20030054410-A1 | Combinatorial protecting group strategy for multifunctional molecules | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-03-20 | — | — | US | claimed |
| WO-2002038578-A1 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF | CHATTOPADHYAYA JYOTI (SE) | 2002-05-16 | — | — | WO | claimed |
| EP-0898575-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KÖSTER, Hubert (US) | 1999-03-03 | — | — | EP | claimed |
| US-5837873-A | PROTECTED OXYDIAMINES | ABBOTT LABORATORIES (US) | 1998-11-17 | — | — | US | claimed |
| EP-0495603-B1 | Hydrogel material | PILKINGTON BARNES HIND INC (US) | 1998-10-14 | — | — | EP | claimed |
| US-5721350-A | Deuterated nucleosides | CHATTOPADHYAYA JYOTI (SE) | 1998-02-24 | — | — | US | claimed |
| WO-1997041139-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT (US) | 1997-11-06 | — | — | WO | claimed |
| US-5362768-A | Polymers for contact lenses | PILKINGTON VISIONCARE, INC. (US) | 1994-11-08 | — | — | US | claimed |
| EP-0456514-B1 | 2-Fluoroneplanocin A and its production | ASAHI CHEMICAL IND (JP) | 1994-10-19 | — | — | EP | claimed |
| US-5332845-A | In DNA synthesis | CHIRON CORPORATION (US) | 1994-07-26 | — | — | US | claimed |
| US-5252760-A | Method of using colored phosphorylating reagents | CHIRON CORPORATION (US) | 1993-10-12 | — | — | US | claimed |
| EP-0495603-A1 | Hydrogel material | Pilkington Visioncare Inc. (a Delaware corp.) (US) | 1992-07-22 | — | — | EP | claimed |
| EP-0456514-A1 | 2-Fluoroneplanocin A and its production | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1991-11-13 | — | — | EP | claimed |
| EP-0180945-B1 | NUCLEOTIDE DERIVATIVE | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1989-05-24 | — | — | EP | claimed |
| EP-0304215-A2 | Phosphorylating reagents and method of using the same | CHIRON CORPORATION (US) | 1989-02-22 | — | — | EP | claimed |
| JP-6135989-A | — | — | None | — | — | JP | disclosed |
| JP-1146885-A | — | — | None | — | — | JP | disclosed |
| WO-2024137329-A1 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | ALEXION PHARMACEUTICALS, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-3737673-B1 | PROCESS FOR PREPARING HALICHONDRIN MACROLIDES AND ANALOGS THEREOF BY A PRINS REACTION, AND INTERMEDIATES OF THIS PROCESS | EISAI R&D MAN CO LTD (JP) | 2024-03-06 | — | — | EP | disclosed |
| US-20230382838-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | AESICA PHARMACEUTICALS LIMITED (GB) | 2023-11-30 | — | — | US | disclosed |
| CN-117024469-A | Macrocyclization reactions useful for the synthesis of halichondrin macrolides, intermediates and other fragments | 卫材R&D管理有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-112250692-B | Macrocyclization reactions useful for the synthesis of halichondrin macrolides, intermediates and other fragments | 卫材R&D管理有限公司 | 2023-08-29 | — | — | CN | disclosed |
| EP-4229026-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | Consort Medical Limited (GB) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023114200-A2 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | ALEXION PHARMACEUTICALS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230151022-A1 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | EISAI R&D MANAGEMENT CO, LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-11643418-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11542269-B2 | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-01-03 | — | — | US | disclosed |
| CN-109311929-B | SECO macrolide compounds | 塞尔维塔公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-114805322-A | Prins reactions and intermediates useful for the synthesis of halichondrin macrolides and analogs thereof | 卫材R&D管理有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114716453-A | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | 卫材R&D管理有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-109942560-B | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | 卫材R&D管理有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-109641917-B | Prins reactions and intermediates useful for the synthesis of halichondrin macrolides and analogs thereof | 卫材R&D管理有限公司 | 2022-06-14 | — | — | CN | disclosed |
| WO-2022084662-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | Consort Medical Limited (GB) | 2022-04-28 | — | — | WO | disclosed |
| EP-3689881-B1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MAN CO LTD (JP) | 2022-01-12 | — | — | EP | disclosed |
| US-11136335-B2 | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2021-10-05 | — | — | US | disclosed |
| US-20210238139-A1 | MODULATORS OF TRYPTOPHAN CATABOLISM | E-THERAPEUTICS PLC (GB) | 2021-08-05 | — | — | US | disclosed |
| US-20210198278-A1 | SECO MACROLIDE COMPOUNDS | SELVITA D.O.O. (HR) | 2021-07-01 | — | — | US | disclosed |
| US-20210188867-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2021-06-24 | — | — | US | disclosed |
| US-10981929-B2 | — | — | 2021-04-20 | — | — | US | disclosed |
| EP-3802503-A1 | UREA DERIVATIVE MODULATORS OF TRYPTOPHAN CATABOLISM | E-Therapeutics plc (GB) | 2021-04-14 | — | — | EP | disclosed |
| US-10961238-B2 | Modulators of hedgehog (Hh) signaling pathway | E-THERAPEUTICS PLC (GB) | 2021-03-30 | — | — | US | disclosed |
| US-10934307-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2021-03-02 | — | — | US | disclosed |
| US-10919910-B2 | Seco macrolide compounds | FIDELTA D.O.O. (HR) | 2021-02-16 | — | — | US | disclosed |
| US-10913749-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2021-02-09 | — | — | US | disclosed |
| CN-112250692-A | Macrocyclization reactions useful for the synthesis of halichondrin macrolides and intermediates and other fragments | 卫材R&D管理有限公司 | 2021-01-22 | — | — | CN | disclosed |
| EP-3737673-A1 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | Eisai R&D Management Co., Ltd. (JP) | 2020-11-18 | — | — | EP | disclosed |
| CN-107849057-B | Macrocyclization reactions and intermediates and other fragments for the synthesis of halichondrin macrolides | 卫材R&D管理有限公司 | 2020-11-10 | — | — | CN | disclosed |
| CN-111868044-A | Prins reaction and compounds useful for the synthesis of halichondrin macrolides and analogs thereof | 卫材R&D管理有限公司 | 2020-10-30 | — | — | CN | disclosed |
| US-20200331928-A1 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2020-10-22 | — | — | US | disclosed |
| EP-3292130-B1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES | EISAI R&D MAN CO LTD (JP) | 2020-09-30 | — | — | EP | disclosed |
| CN-110218213-B | Pyran fused ring compound, preparation method and application thereof | 北京天一绿甫医药科技有限公司 | 2020-09-04 | — | — | CN | disclosed |
| EP-3689881-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | Eisai R&D Management Co., Ltd. (JP) | 2020-08-05 | — | — | EP | disclosed |
| US-20200223864-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2020-07-16 | — | — | US | disclosed |
| US-10611773-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2020-04-07 | — | — | US | disclosed |
| EP-3066102-B1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MAN CO LTD (JP) | 2020-02-26 | — | — | EP | disclosed |
| US-20200055847-A1 | MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY | E-THERAPEUTICS PLC (GB) | 2020-02-20 | — | — | US | disclosed |
| US-10494388-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-12-03 | — | — | US | disclosed |
| US-20190308992-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-10-10 | — | — | US | disclosed |
| CN-110218213-A | The thick cyclics of pyrans, preparation method and use | 北京天一绿甫医药科技有限公司 | 2019-09-10 | — | — | CN | disclosed |
| EP-3532466-A1 | MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY | E-Therapeutics plc (GB) | 2019-09-04 | — | — | EP | disclosed |
| WO-2019136145-A1 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-07-11 | — | — | WO | disclosed |
| US-10308661-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20190161495-A1 | PRINS REACTION AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-05-30 | — | — | US | disclosed |
| US-20190144463-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-05-16 | — | — | US | disclosed |
| EP-3478691-A1 | PRINS REACTION AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | Eisai R&D Management Co., Ltd. (JP) | 2019-05-08 | — | — | EP | disclosed |
| CN-109641917-A | Prins reactions and intermediates useful for the synthesis of halichondrin macrolides and analogs thereof | 卫材R&D管理有限公司 | 2019-04-16 | — | — | CN | disclosed |
| EP-3455234-A1 | SECO MACROLIDE COMPOUNDS | Fidelta d.o.o. (HR) | 2019-03-20 | — | — | EP | disclosed |
| WO-2019043373-A1 | SUBSTITUTED CYCLYL-SULFONAMIDES AS MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY | E-THERAPEUTICS PLC (GB) | 2019-03-07 | — | — | WO | disclosed |
| WO-2019043372-A1 | SUBSTITUTES SULFONYL AZACYCLES AS MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY | E-THERAPEUTICS PLC (GB) | 2019-03-07 | — | — | WO | disclosed |
| US-10221189-B2 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-03-05 | — | — | US | disclosed |
| US-20180162885-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
| WO-2018078360-A1 | MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY | E-THERAPEUTICS PLC (GB) | 2018-05-03 | — | — | WO | disclosed |
| US-20180118755-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-05-03 | — | — | US | disclosed |
| EP-3292130-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES | Eisai R&D Management Co., Ltd. (JP) | 2018-03-14 | — | — | EP | disclosed |
| WO-2018006031-A1 | PRINS REACTION AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-01-04 | — | — | WO | disclosed |
| US-20180002342-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-9856276-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-01-02 | — | — | US | disclosed |
| WO-2017194452-A1 | SECO MACROLIDE COMPOUNDS | FIDELTA D.O.O. (HR) | 2017-11-16 | — | — | WO | disclosed |
| US-9783549-B2 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2017-10-10 | — | — | US | disclosed |
| US-20160376294-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-12-29 | — | — | US | disclosed |
| WO-2016179607-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-11-10 | — | — | WO | disclosed |
| US-20160297830-A1 | NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES | GALAPAGOS NV (BE) | 2016-10-13 | — | — | US | disclosed |
| US-20160264594-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| EP-3066102-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | Eisai R&D Management Co., Ltd. (JP) | 2016-09-14 | — | — | EP | disclosed |
| EP-3041844-A1 | BRANIMYCIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES | Galapagos NV (BE) | 2016-07-13 | — | — | EP | disclosed |
| US-9382262-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-07-05 | — | — | US | disclosed |
| CN-105683198-A | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | 卫材R&D管理有限公司 | 2016-06-15 | — | — | CN | disclosed |
| US-20150175620-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2015-06-25 | — | — | US | disclosed |
| WO-2015066729-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2015-05-07 | — | — | WO | disclosed |
| WO-2015028095-A1 | BRANIMYCIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES | GALAPAGOS NV (BE) | 2015-03-05 | — | — | WO | disclosed |
| US-8927597-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2015-01-06 | — | — | US | disclosed |
| EP-2528914-B1 | FURO[3,2-B]PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MAN CO LTD (JP) | 2014-06-11 | — | — | EP | disclosed |
| US-8470829-B2 | Imidazolidine derivative and use thereof | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20130123519-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-05-16 | — | — | US | disclosed |
| US-8394935-B2 | Method for producing furanose derivative | API CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| US-8350067-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2528914-A1 | FURO [3, 2 -B]PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | Eisai R&D Management Co., Ltd. (JP) | 2012-12-05 | — | — | EP | disclosed |
| US-20120289718-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-11-15 | — | — | US | disclosed |
| WO-2012147900-A1 | MICROREACTOR PROCESS FOR HALICHONDRIN B ANALOG SYNTHESIS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-11-01 | — | — | WO | disclosed |
| US-8203010-B2 | Compounds useful in the synthesis of halichondrin B analogs | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-06-19 | — | — | US | disclosed |
| US-8173824-B2 | Process for producing vitamin D derivative using convergent method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8124196-B2 | Fluorobicyclo[2.2.2]octane compound, method of producing the same, and applications thereof | FUJIFILM CORPORATION (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20110306615-A1 | NOVEL IMIDAZOLIDINE DERIVATIVE AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-12-15 | — | — | US | disclosed |
| WO-2011131749-A1 | NEW 14 AND 15 MEMBERED MACROLIDES FOR THE TREATMENT OF NEUTROPHIL DOMINATED INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2011-10-27 | — | — | WO | disclosed |
| WO-2011094339-A1 | FURO [3, 2 -B] PYRANE DERIVATIVES USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-08-04 | — | — | WO | disclosed |
| US-20110184190-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-07-28 | — | — | US | disclosed |
| US-7985744-B2 | Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-07-26 | — | — | US | disclosed |
| US-20100217020-A1 | PROCESS FOR PRODUCING VITAMIN D DERIVATIVE USING CONVERGENT METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2150533-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | LONZA AG (CH) | 2010-07-14 | — | — | EP | disclosed |
| US-7745438-B2 | 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors | ELI LILLY AND COMPANY (US) | 2010-06-29 | — | — | US | disclosed |
| US-20100130745-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | MCGARRITY JOHN | 2010-05-27 | — | — | US | disclosed |
| US-20100105890-A1 | METHOD FOR PRODUCING FURANOSE DERIVATIVE | API CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| EP-2150533-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | LONZA AG (CH) | 2010-02-10 | — | — | EP | disclosed |
| US-7618978-B2 | Amides as BACE inhibitors | ELI LILLY AND COMPANY (US) | 2009-11-17 | — | — | US | disclosed |
| EP-2105445-A1 | METHOD FOR PRODUCTION OF FURANOSE DERIVATIVE | API Corporation (JP) | 2009-09-30 | — | — | EP | disclosed |
| US-7592407-B2 | a perfluorinated ester compound containing a pyran ring, a hydroxy or protected hydroxy group; able to polymerized into a fluorinated polymer which is used as a base polymer to formulate a resist composition having transparency to laser light; alkali development amenability, and dry etch resistance | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-09-22 | — | — | US | disclosed |
| US-7585885-B2 | Pyrrolidine derivatives useful as BACE inhibitors | ELI LILLY AND COMPANY (US) | 2009-09-08 | — | — | US | disclosed |
| EP-2091928-A2 | 3-(2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS | ELI LILLY AND COMPANY (US) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008131932-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | LONZA AG (CH) | 2008-11-06 | — | — | WO | disclosed |
| EP-1988079-A1 | Process for the preparation of optically active ethenylphenyl-alcohols | LONZA AG (CH) | 2008-11-05 | — | — | EP | disclosed |
| EP-1955999-A1 | METHOD FOR PRODUCING VITAMIN D DERIVATIVE BY USING CONVERGENT METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7312288-B2 | Polymerizable fluorinated ester compounds and their preparing processes | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070249858-A1 | POLYMERIZABLE FLUORINATED ESTER COMPOUNDS AND THEIR PREPARING PROCESSES | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| US-20070225267-A1 | 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors | ELI LILLY AND COMPANY | 2007-09-27 | — | — | US | disclosed |
| US-20070225372-A1 | Amides as Bace Inhibitors | ELI LILLY AND COMPANY | 2007-09-27 | — | — | US | disclosed |
| US-20070213331-A1 | PYRROLIDINE DERIVATIVES USEFUL AS BASE INHIBITORS | ELI LILLY AND COMPANY | 2007-09-13 | — | — | US | disclosed |
| EP-1652846-B1 | Polymerizable fluorinated compound, making method, polymer, resist composition and patterning process | SHINETSU CHEMICAL CO (JP) | 2007-08-22 | — | — | EP | disclosed |
| EP-1790640-A1 | NOVEL IMIDAZOLIDINE DERIVATIVE AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-05-30 | — | — | EP | disclosed |
| EP-1740573-A1 | AMIDES AS BACE INHIBITORS | ELI LILLY AND COMPANY (US) | 2007-01-10 | — | — | EP | disclosed |
| EP-1740575-A2 | PYRROLIDINE DERIVATIVES USEFUL AS BACE INHIBITORS | ELI LILLY AND COMPANY (US) | 2007-01-10 | — | — | EP | disclosed |
| EP-1103300-B1 | ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-20060094817-A1 | Polymerizable fluorinated compound, making method, polymer, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. | 2006-05-04 | — | — | US | disclosed |
| EP-1652846-A1 | Polymerizable fluorinated compound, making method, polymer, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-05-03 | — | — | EP | disclosed |
| WO-2006034093-A2 | 3- (2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS | ELLI LILLY AND COMPANY (US) | 2006-03-30 | — | — | WO | disclosed |
| WO-2005108358-A2 | PYRROLIDINE DERIVATIVES USEFUL AS BACE INHIBITORS | ELI LILLY AND COMPANY (US) | 2005-11-17 | — | — | WO | disclosed |
| WO-2005108391-A1 | AMIDES AS BACE INHIBITORS | ELI LILLY AND COMPANY (US) | 2005-11-17 | — | — | WO | disclosed |
| US-6902654-B2 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-06-07 | — | — | US | disclosed |
| EP-0898575-B1 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT DR (US) | 2004-12-29 | — | — | EP | disclosed |
| EP-1486499-A1 | Endo-2,3-epoxy-7-oxabicylco[2.2.1]heptane-endo-5-carboxylic acid derivative | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2004-12-15 | — | — | EP | disclosed |
| US-6828435-B2 | Three blocking groups are independently removable under 3 different conditions; using new protection schemes and solid phase synthesis, oligonucleotides are obtained in 5' to 3' direction using phosphoamidites and avoiding depurination | HK PHARMACEUTICALS, INC. | 2004-12-07 | — | — | US | disclosed |
| US-6797832-B1 | Process for the production of 5-oxy-7-oxabicyclo [4.1.0] hept-3-ene-3-carboxylic acid esters | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2004-09-28 | — | — | US | disclosed |
| US-20040108198-A1 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2004-06-10 | — | — | US | disclosed |
| US-20040019023-A1 | Vitamin d derivatives | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2004-01-29 | — | — | US | disclosed |
| US-20030194741-A1 | COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-10-16 | — | — | US | disclosed |
| US-20030181742-A1 | Process for the preparation of pregnane derivatives | KURARAY CO., LTD. (JP) | 2003-09-25 | — | — | US | disclosed |
| EP-1325928-A1 | PROCESS FOR THE PREPARATION OF PREGNANE DERIVATIVES | Kuraray Co., Ltd. (JP) | 2003-07-09 | — | — | EP | disclosed |
| EP-1295871-A1 | VITAMIN D DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-20030054410-A1 | Combinatorial protecting group strategy for multifunctional molecules | CAPROTEC BIOANALYTICS GMBH (DE) | 2003-03-20 | — | — | US | disclosed |
| EP-1245569-A1 | PROCESS FOR THE PRODUCTION OF 5-OXY-7-OXABICYCLO- 4.1.0]HEPT-3-E NE-3-CARBOXYLIC ACID ESTERS | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2002-10-02 | — | — | EP | disclosed |
| EP-1103300-A1 | ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-05-30 | — | — | EP | disclosed |
| EP-0898575-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KÖSTER, Hubert (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5869644-A | Synthesis of diverse and useful collections of oligonucleotidies | THE JOHNS HOPKINS UNIVERSITY (US) | 1999-02-09 | — | — | US | disclosed |
| US-5837873-A | PROTECTED OXYDIAMINES | ABBOTT LABORATORIES (US) | 1998-11-17 | — | — | US | disclosed |
| EP-0495603-B1 | Hydrogel material | PILKINGTON BARNES HIND INC (US) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997041139-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT (US) | 1997-11-06 | — | — | WO | disclosed |
| EP-0398391-B1 | 0,0'-Dicyanoethyl-phosphoramidites, a process for their preparation and their use in phosphorylation reactions | CHIRON CORP (US) | 1995-08-16 | — | — | EP | disclosed |
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| EP-0633242-A1 | Heptanoate derivatives | FUJIREBIO Inc. (JP) | 1995-01-11 | — | — | EP | disclosed |
| EP-0436334-B1 | 3-Aminopiperidine derivatives and related nitrogen containing heterocycles | PFIZER (US) | 1994-12-07 | — | — | EP | disclosed |
| US-5362768-A | Polymers for contact lenses | PILKINGTON VISIONCARE, INC. (US) | 1994-11-08 | — | — | US | disclosed |
| EP-0456514-B1 | 2-Fluoroneplanocin A and its production | ASAHI CHEMICAL IND (JP) | 1994-10-19 | — | — | EP | disclosed |
| EP-0291917-B1 | Novel oxetanocins | NIPPON KAYAKU KK (JP) | 1994-08-24 | — | — | EP | disclosed |
| EP-0383531-B1 | 6'-deoxy-6'-halogenoneplanosin A and its production | ASAHI CHEMICAL IND (JP) | 1994-08-10 | — | — | EP | disclosed |
| JP-H06135989-A | NUCLEOTIDE DERIVATIVE | TOAGOSEI CHEM IND CO LTD | 1994-05-17 | — | — | JP | disclosed |
| EP-0416605-B1 | Novel oxetanocin derivatives and their salts as well as use thereof | NIPPON KAYAKU KK (JP) | 1994-04-13 | — | — | EP | disclosed |
| US-5283331-A | Viricides | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1994-02-01 | — | — | US | disclosed |
| US-5214048-A | Viricides, immunosuppressants | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1993-05-25 | — | — | US | disclosed |
| EP-0540742-A1 | OLIGODEOXYRIBONUCLEOTIDES | Shudo, Koichi, Prof. Dr. (JP) | 1993-05-12 | — | — | EP | disclosed |
| EP-0260121-B1 | INOSOSE DERIVATIVES, PRODUCTION AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1993-03-10 | — | — | EP | disclosed |
| US-5187174-A | Biological antigrowth agents | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1993-02-16 | — | — | US | disclosed |
| US-5179084-A | Compounds with adenine groups for treatment of AIDS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1993-01-12 | — | — | US | disclosed |
| EP-0495603-A1 | Hydrogel material | Pilkington Visioncare Inc. (a Delaware corp.) (US) | 1992-07-22 | — | — | EP | disclosed |
| EP-0493722-A1 | 2-Halogeno-oxetanocin A and phosphoric ester thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1992-07-08 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0456514-A1 | 2-Fluoroneplanocin A and its production | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1991-11-13 | — | — | EP | disclosed |
| EP-0240175-B1 | INOSOSE DERIVATIVES AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1991-10-16 | — | — | EP | disclosed |
| US-5041447-A | Viricides | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1991-08-20 | — | — | US | disclosed |
| US-5028598-A | Viricides, treatment of AIDS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1991-07-02 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-5004838-A | Inosose derivatives, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-04-02 | — | — | US | disclosed |
| EP-0416605-A1 | Novel oxetanocin derivatives and their salts as well as use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1991-03-13 | — | — | EP | disclosed |
| EP-0099329-B1 | DITHIO COMPOUNDS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE | Zyma SA (CH) | 1990-10-31 | — | — | EP | disclosed |
| EP-0392403-A1 | Phosphoric acid esters of oxetanocins and process for producing the same as well as use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1990-10-17 | — | — | EP | disclosed |
| EP-0383531-A2 | 6'-deoxy-6'-halogenoneplanosin A and its production | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1990-08-22 | — | — | EP | disclosed |
| US-4946861-A | TREATMENT OF LIVER DISORDERS | ZYMA SA (CH) | 1990-08-07 | — | — | US | disclosed |
| EP-0373216-A1 | CEPHALOSPORIN COMPOUNDS OR THEIR SALTS, PROCESS FOR THEIR PREPARATION, AND PARMACEUTICAL COMPOSITIONS | TEIJIN LIMITED (JP) | 1990-06-20 | — | — | EP | disclosed |
| US-4898986-A | Inosose derivatives, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0151189-B1 | ANTINEOPLASTIC AGENT | TEIJIN LIMITED (JP) | 1990-01-31 | — | — | EP | disclosed |
| EP-0347459-A1 | CEPHALOSPORIN COMPOUNDS OR THEIR SALTS, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS | TEIJIN LIMITED (JP) | 1989-12-27 | — | — | EP | disclosed |
| EP-0334250-A2 | Oxetanocin-related compounds and process for producing same | Nippon Kayaku Kabushiki Kaisha (JP) | 1989-09-27 | — | — | EP | disclosed |
| JP-H01146885-A | PHOSPHORYLATING REAGENT AND ITS USE | CHIRON CORP | 1989-06-08 | — | — | JP | disclosed |
| EP-0180945-B1 | NUCLEOTIDE DERIVATIVE | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1989-05-24 | — | — | EP | disclosed |
| US-4824943-A | Inosose derivatives and production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-04-25 | — | — | US | disclosed |
| US-4818765-A | TREATING LIVER, RESPIRATORY TRACT, VASCULAR DISORDERS | CIBA-GEIGY CORPORATION (US) | 1989-04-04 | — | — | US | disclosed |
| US-4757139-A | 5-fluoro-2'-deoxyuridine derivative, processes for preparing same and antitumor composition containing the same | TEIJIN LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0240175-A1 | Inosose derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1987-10-07 | — | — | EP | disclosed |
| EP-0089812-B1 | N-SUBSTITUTED PSEUDO-AMINOSUGARS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1986-10-01 | — | — | EP | disclosed |
| US-4595678-A | N-substituted pseudo-aminosugars and pharmaceutical compositions containing same | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-06-17 | — | — | US | disclosed |
| EP-0151189-A1 | ANTINEOPLASTIC AGENT | TEIJIN LIMITED (JP) | 1985-08-14 | — | — | EP | disclosed |
| EP-0099329-A1 | Dithio compounds, pharmaceutical preparations containing them and their use | Zyma SA (CH) | 1984-01-25 | — | — | EP | disclosed |
| EP-0089812-A1 | N-substituted pseudo-aminosugars, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1983-09-28 | — | — | EP | disclosed |
| EP-0089812-A1 | N-substituted pseudo-aminosugars, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1983-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (47 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961238-B2 | Modulators of hedgehog (Hh) signaling pathway | SHH, GLI1, SMO | KIF11 4138/4885TK1 1680/4885DUT 3766/4885 |
| US-20110306615-A1 | NOVEL IMIDAZOLIDINE DERIVATIVE AND USE THEREOF | CBR1, NR0B1, CNKSR1 | KIF11 4121/4885TK1 2608/4885DUT 2962/4885 |
| US-20120289718-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | ERLIN1, ERLIN2, MAN1B1 | KIF11 1796/4885TK1 2628/4885DUT 1822/4885 |
| US-20230151022-A1 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | LSS, DHPS, COASY | KIF11 162/4885TK1 1815/4885DUT 234/4885 |
| US-20070249858-A1 | POLYMERIZABLE FLUORINATED ESTER COMPOUNDS AND THEIR PREPARING PROCESSES | H1-4, H1-3, HRH3 | KIF11 1176/4885TK1 2799/4885DUT 1540/4885 |
| US-20210238139-A1 | MODULATORS OF TRYPTOPHAN CATABOLISM | TPH1, KYNU, TPH2 | KIF11 4033/4885TK1 320/4885DUT 2260/4885 |
| US-20200055847-A1 | MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY | SHH, GLI1, SMO | KIF11 4184/4885TK1 1726/4885DUT 3781/4885 |
| US-20180162885-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | ERLIN1, ERLIN2, MAN1B1 | KIF11 1796/4885TK1 2628/4885DUT 1822/4885 |
| US-20210198278-A1 | SECO MACROLIDE COMPOUNDS | SEC61B, SEC16A, SEC61A1 | KIF11 2912/4885TK1 4454/4885DUT 2126/4885 |
| US-20180002342-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, DHPS, ELOB | KIF11 1194/4885TK1 1686/4885DUT 1585/4885 |
| US-20070225372-A1 | Amides as Bace Inhibitors | BACE2, BACE1, APP | KIF11 1940/4885TK1 2829/4885DUT 2999/4885 |
| US-20040142946-A1 | Modified nucleosides and nucleotides and use thereof | RNASEH1, RNASEL, NSUN2 | KIF11 4107/4885TK1 268/4885DUT 17/4885 |
| US-20030194741-A1 | COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | ADAR, RNMT, ATIC | KIF11 3459/4885TK1 2276/4885DUT 161/4885 |
| US-10308661-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides | DHPS, CYP51A1, COASY | KIF11 973/4885TK1 762/4885DUT 1582/4885 |
| US-20100130745-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ETHENYLPHENYL ALCOHOLS | ADH1A, ADH1C, ADH5 | KIF11 307/4885TK1 2903/4885DUT 4479/4885 |
| US-20230382838-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | CNR2, CNR1, C1R | KIF11 2361/4885TK1 4868/4885DUT 3291/4885 |
| US-20160264594-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, DHPS, ELOB | KIF11 1158/4885TK1 1220/4885DUT 2129/4885 |
| US-10494388-B2 | Compounds useful in the synthesis of halichondrin B analogs | ERLIN1, ERLIN2, MAN1B1 | KIF11 1796/4885TK1 2628/4885DUT 1822/4885 |
| US-20030181742-A1 | Process for the preparation of pregnane derivatives | CYP21A2, CYP11B2, CYP17A1 | KIF11 2036/4885TK1 3996/4885DUT 2685/4885 |
| US-20100217020-A1 | PROCESS FOR PRODUCING VITAMIN D DERIVATIVE USING CONVERGENT METHOD | CYP2R1, CYP24A1, VDR | KIF11 2749/4885TK1 4756/4885DUT 252/4885 |
| US-20190144463-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, MAN1B1, DHPS | KIF11 1094/4885TK1 1624/4885DUT 1645/4885 |
| US-20070225267-A1 | 3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors | BACE1, BACE2, APP | KIF11 3406/4885TK1 2430/4885DUT 2346/4885 |
| US-20040108198-A1 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | VDR, GC, CYP24A1 | KIF11 180/4885TK1 824/4885DUT 1066/4885 |
| US-20200331928-A1 | PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | LSS, DHPS, COASY | KIF11 162/4885TK1 1815/4885DUT 234/4885 |
| US-20200223864-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, MAN1B1, DHPS | KIF11 1094/4885TK1 1624/4885DUT 1645/4885 |
| US-20070213331-A1 | PYRROLIDINE DERIVATIVES USEFUL AS BASE INHIBITORS | BACE1, BACE2, PSEN1 | KIF11 4101/4885TK1 1041/4885DUT 1203/4885 |
| US-20180118755-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES | DHPS, CYP51A1, COASY | KIF11 973/4885TK1 762/4885DUT 1582/4885 |
| US-20160297830-A1 | NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES | POLR2E, POLB, POLI | KIF11 4138/4885TK1 221/4885DUT 331/4885 |
| US-10913749-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides | DHPS, CYP51A1, COASY | KIF11 952/4885TK1 1132/4885DUT 1080/4885 |
| US-20040019023-A1 | Vitamin d derivatives | VDR, CYP24A1, CYP2R1 | KIF11 4605/4885TK1 3711/4885DUT 2512/4885 |
| US-20150175620-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | ERLIN1, ERLIN2, MAN1B1 | KIF11 1796/4885TK1 2628/4885DUT 1822/4885 |
| US-10934307-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | ERLIN1, MAN1B1, DHPS | KIF11 1094/4885TK1 1624/4885DUT 1645/4885 |
| US-11643418-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | ERLIN1, MAN1B1, DHPS | KIF11 1241/4885TK1 1193/4885DUT 2178/4885 |
| US-10611773-B2 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | ERLIN1, MAN1B1, DHPS | KIF11 1094/4885TK1 1624/4885DUT 1645/4885 |
| US-11136335-B2 | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof | LSS, DHPS, COASY | KIF11 253/4885TK1 2447/4885DUT 377/4885 |
| US-20100105890-A1 | METHOD FOR PRODUCING FURANOSE DERIVATIVE | DERA, ALDOA, DPYD | KIF11 3714/4885TK1 1349/4885DUT 6/4885 |
| US-10981929-B2 | — | LSS, DHPS, CYP51A1 | KIF11 372/4885TK1 3141/4885DUT 568/4885 |
| US-11542269-B2 | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof | LSS, DHPS, COASY | KIF11 162/4885TK1 1815/4885DUT 234/4885 |
| US-20110184190-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | ERLIN1, ERLIN2, MAN1B1 | KIF11 1796/4885TK1 2628/4885DUT 1822/4885 |
| US-20210188867-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | ERLIN1, MAN1B1, DHPS | KIF11 1241/4885TK1 1193/4885DUT 2178/4885 |
| US-20030054410-A1 | Combinatorial protecting group strategy for multifunctional molecules | ADAR, RNMT, RRM1 | KIF11 3252/4885TK1 1762/4885DUT 86/4885 |
| US-10919910-B2 | Seco macrolide compounds | SEC61B, SEC16A, SEC61A1 | KIF11 2912/4885TK1 4454/4885DUT 2126/4885 |
| US-20160376294-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | ERLIN1, ERLIN2, MAN1B1 | KIF11 1796/4885TK1 2628/4885DUT 1822/4885 |
| US-20130123519-A1 | COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN B ANALOGS | ERLIN1, ERLIN2, MAN1B1 | KIF11 1796/4885TK1 2628/4885DUT 1822/4885 |
| US-20190308992-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES | DHPS, CYP51A1, COASY | KIF11 952/4885TK1 1132/4885DUT 1080/4885 |
| US-10221189-B2 | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | ERLIN1, DHPS, ELOB | KIF11 1194/4885TK1 1686/4885DUT 1585/4885 |
| US-20190161495-A1 | PRINS REACTION AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF | LSS, DHPS, COASY | KIF11 253/4885TK1 2447/4885DUT 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.